Serum carotenoids and Pediatric Metabolic Index predict insulin sensitivity in Mexican American children

Srinivas Mummidi1, Vidya S Farook2, Lavanya Reddivari3

  • 1South Texas Diabetes and Obesity Institute, Department of Human Genetics, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX, USA. srinivas.mummidi@utrgv.edu.

Scientific Reports
|January 14, 2021
PubMed

Insights

Serum carotenoids like lycopene and beta-cryptoxanthin are highly heritable and linked to cardiometabolic health in children. Alpha- and beta-carotenoids show the strongest impact on insulin sensitivity.

Area of Science:

  • Nutritional Biochemistry
  • Human Genetics
  • Pediatric Endocrinology

Background:

  • High carotenoid intake is linked to reduced cardiometabolic risk traits (CMTs).
  • Previous research in Mexican American (MA) children indicated genetic influences on serum carotenoids and CMTs.
  • A Pediatric Metabolic Index (PMI) was previously developed to identify children at risk for cardiometabolic diseases.

Purpose of the Study:

  • To quantify serum lycopene and beta-cryptoxanthin concentrations in MA children.
  • To determine the heritability and correlations of these carotenoids with CMTs.
  • To investigate the interactions of carotenoids and PMI on insulin sensitivity using response surface methodology (RSM).

Main Methods:

  • Ultra-performance liquid chromatography-photodiode array was used to measure serum carotenoid concentrations.
  • Heritability and phenotypic correlations with CMTs (obesity measures, lipids, glucose) were calculated.
  • Response surface methodology (RSM) analyzed interactions between carotenoids, PMI, and Matsuda insulin sensitivity index (ISI).

Main Results:

  • Serum lycopene and beta-cryptoxanthin were highly heritable (h²=0.98 and h²=0.58, respectively).
  • Beta-cryptoxanthin showed significant negative correlations with BMI, waist circumference, triglycerides, fat mass, and fasting glucose, and a positive correlation with HDL cholesterol.
  • Lycopene showed weaker correlations with fasting glucose and HDL cholesterol. Alpha- and beta-carotenoids, not beta-cryptoxanthin or lycopene, maximally impacted ISI.

Conclusions:

  • Serum carotenoid concentrations are strongly influenced by additive genetic factors in MA children.
  • Beta-cryptoxanthin demonstrates a protective association with multiple CMTs.
  • Different carotenoids may have distinct roles in metabolic health and susceptibility to CMTs in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
412